ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-12 |

Results: 12

OPTIMAL CONDITIONS FOR THE ADENOVIRUS-P53 PURGING OF HUMAN PERIPHERAL-BLOOD STEM-CELL PRODUCTS

Authors: TALMADGE JE HIRAI M KELSEY L QIAN F WATANABE T VAILLANCOURT M MANEVAL DC

Citation: Je. Talmadge et al., OPTIMAL CONDITIONS FOR THE ADENOVIRUS-P53 PURGING OF HUMAN PERIPHERAL-BLOOD STEM-CELL PRODUCTS, Cancer gene therapy, 4(6), 1997, pp. 80-80

ADENOVIRUS-P53 MEDIATED TRANSDUCTION OF HUMAN CD34-CELLS( STEM)

Authors: TALMADGE JE WATANABE T HIRAI M KELSEY L KUSZYNSKI C VAILLANCOURT M MANEVAL DC

Citation: Je. Talmadge et al., ADENOVIRUS-P53 MEDIATED TRANSDUCTION OF HUMAN CD34-CELLS( STEM), Cancer gene therapy, 4(6), 1997, pp. 81-81

ANTIVIRAL PROPERTIES OF PALINAVIR, A POTENT INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE

Authors: LAMARRE D CROTEAU G WARDROP E BOURGON L THIBEAULT D CLOUETTE C VAILLANCOURT M COHEN E PARGELLIS C YOAKIM C ANDERSON P

Citation: D. Lamarre et al., ANTIVIRAL PROPERTIES OF PALINAVIR, A POTENT INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 965-971

OPTIMAL CONDITIONS FOR THE ADENOVIRUS-P53 PURGING OF BREAST-CANCER STEM-CELL PRODUCTS

Authors: HIRAI M KELSEY L QIAN F VAILLANCOURT M MANEVAL DC TALMADGE JE

Citation: M. Hirai et al., OPTIMAL CONDITIONS FOR THE ADENOVIRUS-P53 PURGING OF BREAST-CANCER STEM-CELL PRODUCTS, Blood, 90(10), 1997, pp. 949-949

HIGH-EFFICIENCY ADENOVIRUS-MEDIATED GENE-TRANSFER INTO HUMAN CD34-CELLS( HEMATOPOIETIC)

Authors: WATANABE T KUSZYNSKI C INO K HEIMANN DG VAILLANCOURT M SHEPARD HM MANEVAL DC TALMADGE JE

Citation: T. Watanabe et al., HIGH-EFFICIENCY ADENOVIRUS-MEDIATED GENE-TRANSFER INTO HUMAN CD34-CELLS( HEMATOPOIETIC), Cancer gene therapy, 3(6), 1996, pp. 63-63

CHARACTERIZATION OF DYNAMIC STATE INHIBITORS OF HIV-1 PROTEASE

Authors: VAILLANCOURT M COHEN E SAUVE G

Citation: M. Vaillancourt et al., CHARACTERIZATION OF DYNAMIC STATE INHIBITORS OF HIV-1 PROTEASE, Journal of enzyme inhibition, 9(3), 1995, pp. 217-233

KINETIC CHARACTERIZATION OF HIV-1 PROTEASE MUTANTS SELECTED UNDER IN-VITRO DRUG PRESSURE

Authors: GULNIK SV SUVOROV LI LIU B YU B ANDERSON B MITSUYA H VAILLANCOURT M SWANSTROM R ERICKSON JW

Citation: Sv. Gulnik et al., KINETIC CHARACTERIZATION OF HIV-1 PROTEASE MUTANTS SELECTED UNDER IN-VITRO DRUG PRESSURE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 59-59

SEQUENCE-ANALYSIS OF VIRAL-RNA FROM PATIENTS ON AZT-SAQUINAVIR DOUBLETHERAPY (ACTG-229)

Authors: VAILLANCOURT M IRLBECK D SWANSTROM R

Citation: M. Vaillancourt et al., SEQUENCE-ANALYSIS OF VIRAL-RNA FROM PATIENTS ON AZT-SAQUINAVIR DOUBLETHERAPY (ACTG-229), Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 74-74

ANTIVIRAL PROPERTIES OF SIMPLE DIFUNCTIONALIZED ENOLS TARGETED TO THEHIV-1 PROTEASE

Authors: VAILLANCOURT M SAUVE G COHEN E

Citation: M. Vaillancourt et al., ANTIVIRAL PROPERTIES OF SIMPLE DIFUNCTIONALIZED ENOLS TARGETED TO THEHIV-1 PROTEASE, Antiviral research, 27(3), 1995, pp. 205-218

SIMULTANEOUS EVALUATION OF THE REFRACTIVE-INDEX AND OXIDE FILM THICKNESS OF THERMALLY OXIDIZED ZR-NB ALLOYS

Authors: VAILLANCOURT M KHATAMIAN D MAGUIRE MA

Citation: M. Vaillancourt et al., SIMULTANEOUS EVALUATION OF THE REFRACTIVE-INDEX AND OXIDE FILM THICKNESS OF THERMALLY OXIDIZED ZR-NB ALLOYS, Journal of nuclear materials, 227(1-2), 1995, pp. 58-65

'EXOTISME'

Authors: VAILLANCOURT M

Citation: M. Vaillancourt, 'EXOTISME', Liberte, 36(4), 1994, pp. 137-138

DIFUNCTIONAL ENOLS OF N-PROTECTED AMINO-ACIDS AS LOW-MOLECULAR-WEIGHTAND NOVEL INHIBITORS OF HIV-1 PROTEASE

Authors: VAILLANCOURT M VANASSE B COHEN E SAUVE G

Citation: M. Vaillancourt et al., DIFUNCTIONAL ENOLS OF N-PROTECTED AMINO-ACIDS AS LOW-MOLECULAR-WEIGHTAND NOVEL INHIBITORS OF HIV-1 PROTEASE, Bioorganic & medicinal chemistry letters, 3(6), 1993, pp. 1169-1174

Risultati: 1-12 |